Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMDC.L Regulatory News (MDC)

  • There is currently no data for MDC

Form 8.3 -MEDICLINIC INTERNATIONAL PLC

26 Apr 2023 13:44

RNS Number : 5754X
Barclays PLC
26 April 2023
Β 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

Β 

Barclays PLC.

(b)

Owner or controller of interest and short

Β 

Β 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

MEDICLINIC INTERNATIONAL PLC

Β 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

Β 

Β 

offeror/offeree, state this and specify identity of

Β 

offeror/offeree:

(e)

Date position held/dealing undertaken:

25 Apr 2023

(f)

In addition to the company in 1(c) above, is the discloser making

NO

Β 

Β 

Β 

disclosures in respect of any other party to the offer?

Β 

Β 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

Β 

Β 

to which the disclosure relates following the dealing(if any)

Β 

Class of relevant security:

10p ordinary

Β 

Interests

Short Positions

Β 

Number

(%)

Number

(%)

(1)

Relevant securities owned

Β 

Β 

Β 

Β 

Β 

and/or controlled:

Β 

Β 

16,135,345

2.19%

11,176,327

1.52%

(2)

Cash-settled derivatives:

Β 

Β 

Β 

Β 

Β 

and/or controlled:

Β 

Β 

10,423,716

1.41%

13,255,896

1.80%

(3)

Stock-settled derivatives (including options)

Β 

Β 

Β 

Β 

Β 

and agreements to purchase/sell:

Β 

Β 

0

0.00%

0

0.00%

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

TOTAL:

Β 

Β 

26,559,061

3.60%

24,432,223

3.31%

(b)

Rights to subscribe for new securities (including directors and other executive

Β 

Β 

options)

Β 

Β 

Β 

Β 

Β 

Β 

Class of relevant security in relation to

Β 

Β 

Β 

Β 

which subscription right exists

Β 

Β 

Β 

Β 

Details, including nature of the rights

Β 

Β 

Β 

Β 

concerned and relevant percentages:

Β 

Β 

Β 

Β 

3.

DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(a)

Purchases and sales

Β 

Β 

Β 

Β 

Β 

Class of relevant

Purchase/sale

Number of

Price per unit

security

Β 

securities

Β 

10p ordinary

Purchase

6

4.9900 GBP

10p ordinary

Purchase

23

4.9960 GBP

10p ordinary

Purchase

68

4.9920 GBP

10p ordinary

Purchase

471

4.9880 GBP

10p ordinary

Purchase

806

4.9944 GBP

10p ordinary

Purchase

3,585

4.9883 GBP

10p ordinary

Purchase

5,448

4.9864 GBP

10p ordinary

Purchase

12,368

4.9916 GBP

10p ordinary

Purchase

13,304

4.9940 GBP

10p ordinary

Purchase

13,558

4.9892 GBP

10p ordinary

Purchase

20,036

4.9937 GBP

10p ordinary

Purchase

67,008

4.9906 GBP

10p ordinary

Purchase

200,000

112.5400 ZAR

10p ordinary

Purchase

284,932

113.7000 ZAR

10p ordinary

Sale

110

4.9960 GBP

10p ordinary

Sale

517

4.9925 GBP

10p ordinary

Sale

839

4.9920 GBP

10p ordinary

Sale

1,013

4.9890 GBP

10p ordinary

Sale

1,410

4.9880 GBP

10p ordinary

Sale

2,142

4.9931 GBP

10p ordinary

Sale

3,623

4.9891 GBP

10p ordinary

Sale

4,197

4.9937 GBP

10p ordinary

Sale

6,442

4.9888 GBP

10p ordinary

Sale

18,035

4.9896 GBP

10p ordinary

Sale

21,610

4.9940 GBP

10p ordinary

Sale

22,305

4.9894 GBP

10p ordinary

Sale

75,141

4.9881 GBP

10p ordinary

Sale

76,774

4.9883 GBP

10p ordinary

Sale

200,000

112.5400 ZAR

10p ordinary

Sale

284,932

113.7000 ZAR

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(b)

Cash-settled derivative transactions

Β 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

Β 

reference

unit

security

Β 

Β 

securities

Β 

10p ordinary

SWAP

Long

162

4.9909 GBP

10p ordinary

CFD

Long

750

4.9995 GBP

10p ordinary

SWAP

Long

894

113.2011 ZAR

10p ordinary

SWAP

Long

1,750

4.9919 GBP

10p ordinary

SWAP

Long

2,142

4.9931 GBP

10p ordinary

SWAP

Long

3,129

4.9940 GBP

10p ordinary

SWAP

Long

3,607

113.2423 ZAR

10p ordinary

SWAP

Long

6,051

113.3134 ZAR

10p ordinary

SWAP

Long

11,064

113.2819 ZAR

10p ordinary

CFD

Long

11,240

113.0779 ZAR

10p ordinary

SWAP

Long

20,555

4.9892 GBP

10p ordinary

SWAP

Long

24,438

4.9867 GBP

10p ordinary

CFD

Long

37,928

113.1420 ZAR

10p ordinary

CFD

Long

50,792

4.9880 GBP

10p ordinary

SWAP

Long

50,930

113.1754 ZAR

10p ordinary

SWAP

Long

76,774

4.9883 GBP

10p ordinary

CFD

Long

200,000

112.5287 ZAR

10p ordinary

CFD

Long

284,932

113.6886 ZAR

10p ordinary

CFD

Short

33

4.9942 GBP

10p ordinary

SWAP

Short

68

4.9920 GBP

10p ordinary

CFD

Short

750

4.9924 GBP

10p ordinary

SWAP

Short

806

4.9944 GBP

10p ordinary

CFD

Short

894

113.2322 ZAR

10p ordinary

SWAP

Short

3,607

113.2423 ZAR

10p ordinary

SWAP

Short

5,448

4.9864 GBP

10p ordinary

SWAP

Short

6,051

113.3134 ZAR

10p ordinary

SWAP

Short

11,064

113.2819 ZAR

10p ordinary

SWAP

Short

11,240

113.1090 ZAR

10p ordinary

SWAP

Short

15,521

4.9940 GBP

10p ordinary

SWAP

Short

27,088

4.9913 GBP

10p ordinary

CFD

Short

37,790

4.9902 GBP

10p ordinary

SWAP

Short

37,928

113.1760 ZAR

10p ordinary

CFD

Short

50,930

113.2093 ZAR

10p ordinary

SWAP

Short

200,000

112.5400 ZAR

10p ordinary

SWAP

Short

284,932

113.7000 ZAR

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(c)

Stock-settled derivative transactions (including options)

Β 

(i)

Writing, selling, purchasing or varying

Β 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

Β 

date

money

relevant

Β 

selling,

securities

per unit

Β 

Β 

paid/

security

Β 

varying etc

to which

Β 

Β 

Β 

received

Β 

Β 

Β 

option

Β 

Β 

Β 

per unit

Β 

Β 

Β 

relates

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(ii)

Exercising

Β 

Β 

Β 

Β 

Β 

Β 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

Β 

Β 

securities

unit

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(d)

Other dealings (including subscribing for new securities)

Β 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

Β 

Β 

applicable)

Β 

Β 

Β 

Β 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding,

Β 

Β 

formal or informal, relating to relevant securities which may be an inducement to deal

Β 

Β 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

Β 

to the offer or any person acting in concert with a party to the offer:

Β 

Β 

Β 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between

Β 

Β 

the person making the disclosure and any other person relating to:

Β 

Β 

(i) the voting rights of any relevant securities under any option; or

Β 

Β 

Β 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

Β 

Β 

any derivative is referenced:

Β 

Β 

Β 

Β 

Β 

Β 

NONE

(c)

Attachments

Β 

Β 

Β 

Β 

Β 

Β 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

26 Apr 2023

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETIFMTTMTITBBJ
Date   Source Headline
26th May 20234:36 pmRNSForm 8 (DD) - Mediclinic International plc
26th May 20232:45 pmRNSForm 8.3 - MEDICLINIC INTERNATIONAL PLC
26th May 20231:00 pmRNSForm 8.3 - Mediclinic International plc
26th May 202311:33 amRNSForm 8.5 (EPT/NON-RI) - Mediclinic International p
26th May 202311:28 amRNSForm 8.5 (EPT/RI) - Mediclinic International plc
26th May 202311:18 amRNSForm 8.5 (EPT/NON-RI)-Mediclinic International plc
26th May 202310:45 amRNSForm 8.5 (EPT/RI)- Mediclinic International plc
26th May 20239:29 amRNSForm 8.5 (EPT/NON-RI)
26th May 20238:00 amRNSScheme of Arrangement becomes effective
26th May 20237:00 amRNSForm 8.3 - Mediclinic International plc
25th May 20233:20 pmRNSForm 8.3 - Mediclinic International plc
25th May 20232:57 pmRNSForm 8 (DD) - Mediclinic International plc
25th May 20232:39 pmRNSForm 8.5 (EPT/RI) - Mediclinic International plc
25th May 20232:12 pmRNSForm 8.3 - Mediclinic International plc
25th May 20232:00 pmRNSDirector/PDMR Shareholding
25th May 20232:00 pmRNSForm 8 (DD) - Mediclinic International plc
25th May 20232:00 pmRNSForm 8 (DD) - Mediclinic International plc
25th May 20232:00 pmRNSForm 8 (DD) - Mediclinic International plc
25th May 20231:37 pmRNSForm 8.5 (EPT/RI)- Replacement of Mediclinic
25th May 20231:00 pmRNSCourt Sanction of Scheme of Arrangement
25th May 202311:26 amRNSForm 8.5 (EPT/NON-RI) - Mediclinic International p
25th May 202311:25 amRNSForm 8.5 (EPT/RI) - Mediclinic
25th May 202310:48 amRNSForm 8.5 (EPT/NON-RI)-Mediclinic International plc
25th May 202310:34 amRNSForm 8.5 (EPT/RI)- Mediclinic International plc
25th May 202310:34 amRNSForm 8.5 (EPT/RI)
24th May 20233:20 pmRNSForm 8.3 - Mediclinic International plc
24th May 20232:17 pmRNSForm 8.3 - Mediclinic International PLC
24th May 202312:10 pmEQSForm 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
24th May 202312:00 pmRNSForm 8.3 - MEDICLINIC INTERNATIONAL PLC
24th May 202311:10 amRNSForm 8.5 (EPT/NON-RI)
24th May 202311:00 amRNSForm 8.5 (EPT/RI) - Mediclinic International plc
24th May 202311:00 amRNSForm 8.5 (EPT/RI) - Mediclinic Amendment
24th May 202311:00 amRNSForm 8.5 (EPT/NON-RI) - Mediclinic International
24th May 202310:32 amRNSForm 8.5 (EPT/NON-RI)-Mediclinic International plc
24th May 202310:18 amRNSForm 8.5 (EPT/RI)- Mediclinic International plc
24th May 20239:30 amRNSConsideration Currency Exchange Rate
23rd May 20234:47 pmRNSForm 8.5 (EPT/RI)-Replacement of Mediclinic
23rd May 20233:20 pmRNSForm 8.3 - Mediclinic International plc
23rd May 20233:19 pmRNSForm 8.3 - Mediclinic International plc
23rd May 20233:00 pmRNSForm 8.3 - Mediclinic International Plc
23rd May 202312:50 pmRNSForm 8 (DD) - Mediclinic International plc
23rd May 202312:19 pmRNSForm 8.3 - MEDICLINIC INTERNATIONAL PLC
23rd May 202311:39 amRNSForm 8.3 - Mediclinic International plc
23rd May 202311:21 amRNSForm 8.5 (EPT/RI) - Mediclinic
23rd May 202310:49 amRNSForm 8.5 (EPT/NON-RI) - Mediclinic
23rd May 202310:15 amRNSForm 8.5 (EPT/RI) - Mediclinic International plc
23rd May 202310:13 amRNSForm 8.5 (EPT/NON-RI)-Mediclinic International plc
22nd May 20236:01 pmRNSMediclinic International
22nd May 20233:42 pmRNSForm 8.3 - Mediclinic International Plc
22nd May 20233:34 pmRNSForm 8.3 - Mediclinic International Plc

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.